Y-mAbs Therapeutics, Inc.
We are a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.
$14.00 - $16.00
BofA Merrill Lynch, Cowen, Canaccord Genuity, BTIG
To view the prospectus for Y-mAbs Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277